Preoperative thyroglobulin antibody concentrations and prediction of papillary thyroid carcinoma recurrence

被引:0
作者
Ge, Jiawei [1 ]
Lin, Bo [2 ]
Sun, Yijia [1 ]
Li, Xuyang [1 ]
Chen, Wanna [2 ]
Yu, Shuang [1 ]
Liu, Junfeng [3 ]
Liu, Yihao [4 ]
Li, Bin [4 ]
Lv, Weiming [2 ]
Li, Yanbing [1 ]
Huo, Zijun [1 ]
Alexander, Erik K. [5 ]
Xiao, Haipeng [1 ]
Hong, Shubin [1 ]
机构
[1] Sun Yat sen Univ, Affiliated Hosp 1, Dept Endocrinol, Guangzhou, Peoples R China
[2] Sun Yat sen Univ, Affiliated Hosp 1, Dept Thyroid Surg, Guangzhou, Peoples R China
[3] Sun Yat sen Univ, Affiliated Hosp 1, Dept Med Records, Guangzhou, Peoples R China
[4] Sun Yat sen Univ, Affiliated Hosp 1, Clin Trials Unit, Guangzhou, Peoples R China
[5] Brigham & Womens Hosp, Dept Med, Div Endocrinol Diabet & Hypertens, Boston, MA 02115 USA
基金
中国国家自然科学基金;
关键词
Autoimmune thyroiditis; Thyroglobulin antibody; Thyroid peroxidase antibody; Papillary thyroid carcinoma; Recurrence; HASHIMOTOS-THYROIDITIS; CLINICAL UTILITY; CANCER; AUTOIMMUNE; ASSOCIATION; PREVALENCE; PROGNOSIS; DISEASE; RISK;
D O I
10.1007/s12020-025-04343-3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective Autoimmune thyroiditis (AIT), a common chronic autoimmune inflammation of the thyroid, has been associated with an elevated risk of papillary thyroid carcinoma (PTC). However, the impact of AIT on the prognosis of PTC remains uncertain. As thyroid autoantibodies were indicators for AIT, this study aimed to investigate the recurrence risk in different levels of preoperative thyroid autoantibodies in PTC patients. Methods This retrospective study analyzed 1122 PTC patients undergoing total thyroidectomy or lobectomy. We assessed associations of preoperative antithyroglobulin (TGAb) and antithyroid peroxidase antibodies (TPOAb) with cancer recurrence using Cox regression, restricted cubic spline models and subgroup analysis. Results The median follow-up for all patients was 40 months (95%CI, 37.9-41.9) and the 3-year recurrence-free survival rate was 86.6%. Elevated TGAb >15 IU/mL independently predicted cancer recurrence risk (HR, 2.56; 95% CI, 1.21-5.44; P = 0.014). In contrast, increasing TPOAb levels were associated with a trend toward decreased risk of PTC recurrence (P for trend = 0.037), though the highest quartile (TPOAb >50 IU/mL) was not independently significant after adjustment (HR, 0.69; 95% CI, 0.41-1.15; P = 0.157). In combination, TGAb > 15 IU/mL and TPOAb <= 50 IU/mL predicted the highest recurrence risk (HR, 4.52; 95% CI, 1.54-13.29, P = 0.006). Female patients or patients < 55 years old with TGAb > 15 IU/mL and TPOAb <= 50 IU/mL had more risk of recurrence (HR, 4.68, 95% CI, 1.36-16.07; P = 0.014; HR, 5.27, 95% CI, 1.54-17.98; P = 0.008). Conclusion Preoperative TGAb, but not TPOAb, is an independent prognostic factor for PTC. The elevation of preoperative TGAb correlates with an increased recurrence rate of PTC. PTC patients with elevated preoperative TGAb levels may necessitate greater clinical attention owing to higher recurrence rates, which challenges the conventional notion that PTC concomitant with AIT is invariably indolent.
引用
收藏
页数:11
相关论文
共 48 条
[1]   Hashimoto thyroiditis: Clinical and diagnostic criteria [J].
Caturegli, P. ;
De Remigis, A. ;
Rose, N. R. .
AUTOIMMUNITY REVIEWS, 2014, 13 (4-5) :391-397
[2]   Hashimoto's Thyroiditis: Celebrating the Centennial Through the Lens of the Johns Hopkins Hospital Surgical Pathology Records [J].
Caturegli, Patrizio ;
De Remigis, Alessandra ;
Chuang, Kelly ;
Dembele, Marieme ;
Iwama, Akiko ;
Iwama, Shintaro .
THYROID, 2013, 23 (02) :142-150
[3]   Thyroid Antibody Status, Subclinical Hypothyroidism, and the Risk of Coronary Heart Disease: An Individual Participant Data Analysis [J].
Collet, Tinh-Hai ;
Bauer, Douglas C. ;
Cappola, Anne R. ;
Asvold, Bjorn O. ;
Weiler, Stefan ;
Vittinghoff, Eric ;
Gussekloo, Jacobijn ;
Bremner, Alexandra ;
den Elzen, Wendy P. J. ;
Maciel, Rui M. B. ;
Vanderpump, Mark P. J. ;
Cornuz, Jacques ;
Doerr, Marcus ;
Wallaschofski, Henri ;
Newman, Anne B. ;
Sgarbi, Jose A. ;
Razvi, Salman ;
Voelzke, Henry ;
Walsh, John P. ;
Aujesky, Drahomir ;
Rodondi, Nicolas .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2014, 99 (09) :3353-3362
[4]   A Prospective Multicenter Study Examining the Relationship Between Thyroid Cancer Treatment Outcomes and the Presence of Autoimmune Thyroiditis [J].
De Leo, Simone ;
D'Elia, Silvia ;
Grani, Giorgio ;
Dondi, Francesco ;
Bertagna, Francesco ;
Puxeddu, Efisio ;
Morelli, Silvia ;
Piovesan, Alessandro ;
Nervo, Alice ;
Zatelli, Maria Chiara ;
Gagliardi, Irene ;
Sama, Maria Teresa ;
Aimaretti, Gianluca ;
Crocetti, Umberto ;
Massa, Michela ;
Deandrea, Maurilio ;
Retta, Francesca ;
Pagano, Loredana ;
Rossi, Mattia ;
Solaroli, Erica ;
Pezzullo, Luciano ;
Chiofalo, Maria Grazia ;
Pontecorvi, Alfredo ;
Lombardi, Celestino Pio ;
Antonelli, Alessandro ;
Patrizio, Armando ;
Messuti, Ilaria ;
Magri, Flavia ;
Spiazzi, Giovanna ;
Ceresini, Graziano ;
Bruno, Rocco ;
Sparano, Clotilde ;
Centanni, Marco ;
Crescenzi, Anna ;
Tallini, Giovanni ;
Marotta, Vincenzo ;
Madeo, Bruno ;
Mian, Caterina ;
Filetti, Sebastiano ;
Durante, Cosimo ;
Fugazzola, Laura .
THYROID, 2023, 33 (11) :1318-1326
[5]   The Impact of Hashimoto Thyroiditis on Thyroid Nodule Cytology and Risk of Thyroid Cancer [J].
de Morais, Nathalie Silva ;
Stuart, Jessica ;
Guan, Haixia ;
Wang, Zhihong ;
Cibas, Edmund S. ;
Frates, Mary C. ;
Benson, Carol B. ;
Cho, Nancy L. ;
Nehs, Mathew A. ;
Alexander, Caroline A. ;
Marqusee, Ellen ;
Kim, Mathew, I ;
Lorch, Jochen H. ;
Barletta, Justine A. ;
Angell, Trevor E. ;
Alexander, Erik K. .
JOURNAL OF THE ENDOCRINE SOCIETY, 2019, 3 (04) :791-800
[6]   Association between Hashimoto's Thyroiditis and Thyroid Cancer in 64,628 Patients [J].
de Paiva, Christina Resende ;
Gronhoj, Christian ;
Feldt-Rasmussen, Ulla ;
von Buchwald, Christian .
FRONTIERS IN ONCOLOGY, 2017, 7
[7]   Mesenchymal stem cells alleviate autoimmune thyroiditis by modulating macrophage phenotypes and through influencing the STING pathway [J].
Ding, Haoran ;
Qin, Jiabo ;
Liu, Zhijian ;
Shi, Xianbiao ;
Guan, Wenxian ;
Sang, Jianfeng .
TISSUE & CELL, 2024, 91
[8]   Differentiated Thyroid Cancer Is Associated With Less Aggressive Disease and Better Outcome in Patients With Coexisting Hashimotos Thyroiditis [J].
Dvorkin, Shelleg ;
Robenshtok, Eyal ;
Hirsch, Dania ;
Strenov, Yulia ;
Shimon, Ilan ;
Benbassat, Carlos A. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2013, 98 (06) :2409-2414
[9]   Prognostic markers in well differentiated papillary and follicular thyroid cancer (WDTC) [J].
Gillanders, S. L. ;
O'Neill, J. P. .
EJSO, 2018, 44 (03) :286-296
[10]  
Gilliland FD, 1997, CANCER-AM CANCER SOC, V79, P564, DOI 10.1002/(SICI)1097-0142(19970201)79:3<564::AID-CNCR20>3.0.CO